from this site
"The literature suggests that premature infants and those with underlying medical conditions may be at highest risk for developing E. sakazakii infection. Several outbreaks have occurred in neonatal intensive care units worldwide. (See, for example, van Acker et al.(3).) However, an apparently healthy full term newborn infant in Iceland also became ill prior to hospital discharge and suffered permanent neurological sequelae (4). Although the reservoir of the organism is unknown, a growing number of outbreaks of infection among neonates has provided compelling evidence that milk-based powdered infant formulas have served as the source of infection (3-5). Significantly, the results of one investigation (the "Belgium outbreak" investigation (3)) suggest that even low levels of E. sakazakii in milk-based powdered infant formula (i.e., levels that are within what a 1994 Codex Alimentarius document (6) provides as a currently accepted limit for the presence of coliforms in milk-based powdered infant formula) can lead to development of infection."
and this page: www.invs.sante.fr/presse/2005/le_point_sur/salmonella_agona_040505/. is not opening today. It opened yesterday when I linked it to another thread yesterday in 'Living Overseas' I think.
the text from the cached copy is in French so I have provided the translation here using Google Translate.
Outbreak of salmonellosis due to Salmonella enterica serotype Agona in infants,
linked with the consumption of milk powders
France, January-April 2005
InVS point of the investigation in May 3, 2005
The Institute for Public Health is coordinating the investigation of a nationwide outbreak of salmonellosis due to Salmonella enterica serotype Agona occurred in infants since the beginning of 2005.
This investigation showed that this outbreak was linked to the consumption of powdered infant milk. To date, 123 infants with salmonellosis due to Salmonella Agona, were identified by the National Reference Center (NRC) for Salmonella. Families of 115 infants were interviewed.
This outbreak took place in two phases (Figure 1): the first phase in late December 2004 to mid-March 2005 was linked to the consumption of powdered milk brand Picot and involved 44 cases. Withdrawal and recall of baby products brand Picot took place March 4. The second phase associated with the consumption of several batches of milk powder brand Blédilait products in the same establishment as powdered milk Picot began during the fourth week of March and involved 69 cases. Withdrawal and a reminder of those lots was held on April 7.
The progress of investigations is detailed below.
Figure 1 - Weekly Distribution of the 115 infants (whose parents were interviewed) with salmonellosis due to Salmonella Agona, by week of symptom onset and in the milk consumed within 3 days of onset of symptoms, France, January- April 2005
Description of cases
To date, 123 infants aged 1 to 12 months, with salmonellosis in Salmonella Agona diagnosed between January and April 2005 were identified by the NRC for Salmonella.
The 115 infants whose families were interviewed live in 47 different departments (Figure 2). They developed symptoms of salmonellosis between 28 December 2004 and April 21, 2005. One hundred and eleven (97%) children had diarrhea, 68 (59%) with blood in stools and 88 (77%) fever. Forty-two (37%) children were hospitalized. The outcome was favorable for all.
Figure 2 - Geographic distribution of the 115 infants (whose parents were interviewed) with salmonellosis due to Salmonella Agona according to the department of residence. France, January-April 2005
Progress of investigations
On March 3, 2005, the CNR of Salmonella reported to InVS excessive strains Salmonella enterica serotype Agona for the period January-February 2005: 22 strains of S. Agona were isolated in January-February 2005 against eight strains averaged over the same period over the last five years. An epidemiological investigation was carried out by InVS to confirm the epidemic nature of the phenomenon, to measure the importance of generating hypotheses on the origin and source of the outbreak and to propose measures control and prevention measures.
Phase 1
March 4, parents of 19 children patients were asked about their food consumption, they had all eaten milk brand Picot in three days preceding the date of symptom onset.
Given these initial investigations, the producing establishment, in conjunction with the Directorate General for Competition, Consumption and Fraud Control (DGCCRF) and the Directorate General of Health (DGS), decided on March 4 the cessation of production, withdrawal of marketing and recall of all milk brand Picot.
A case-control study compared the food intake of 23 sick children ("cases") to that of 23 children without disease ("controls") of the same age, identified in the practice of physicians treating cases and laboratories that had isolated salmonella. All sick children had consumed milk Picot and none of the children do not ill had eaten.
A survey by the DGCCRF in the producing establishment has identified the manufacturing process of powdered milk, the types of products manufactured on the same chain of production and distribution areas. Environmental levies, milk powder and raw materials have been made. Seven strains of Salmonella Agona were isolated from environmental samples and milk powder. The molecular profile of these strains was identical to strains isolated from patients consuming milk Picot.
The results of these surveys have confirmed that milk powder brand Picot were the source of infection Salmonella Agona occurred in early 2005 in infants in France.
Withdrawal and recall of milk powders, March 4, has prevented the occurrence of new cases linked to the consumption of milk powders. Indeed, only four cases whose parents were not informed of the recall became infected after this date. No new cases have consumed powders that mark has been identified since April 18, 2005. In total, 44 infants were ill after consuming milk powder brand Picot.
Phase 2
During the fourth week of March, the NRC has been a further increase in the number of infants infected with Salmonella Agona. The questioning of the parents of these infants showed that they had all eaten within three days preceding the date of early symptoms of powdered milk brand Blédilait / Gallia 2nd age.
Meanwhile, the investigation of the DGCCRF in establishing producer of infant formula Picot showed that batches of infant milk powder brand Blédilait 2nd age were manufactured on the same production line as powdered milk brand Picot.
Milk powders Blédilait consumed by sick children belonged to the same batch (referenced below). The molecular profile of the strains isolated from patients consuming milk powders Blédilait was the same as strains isolated from sick consumers of milk powders Picot.
Samples of milk powders collected in boxes that had been consumed by sick infants were tested: strains Salmonella Agona were isolated from a second box Blédilait age and a lot 1229/BL7 box Blédilait second batch 1231/BL9 age.
The results of these surveys have confirmed that the batches of milk powder brand Blédilait products on the same production line as powdered milk brand Picot were the cause of cases of this second phase.
On 7 April, the company was implementing Blédina the withdrawal of marketing and recall of these lots:
- Gallia 2: 450g - Dec 06 - Lot: 1210/BLJ
- Gallia 2: 900g - Dec 06 - Lot 1211/BLK
- Blédilait 2: 450g - Dec 06 - Lots: 1210/BLJ and 1229/BL7
- Blédilait 2: 900g - Dec 06 - Lots: 1221/BLX, and 1229/BL7 1231/BL9
In total, 69 infants sick after consuming milk powder brand Blédilait have been identified to date.
These children have symptoms of salmonellosis between March 21 and April 21, 2005. Among them, 3 children sick on March 31, April 10 and April 21 had consumed milk powder batches belonging to Blédilait 2 JAN07 290 DNH (2 cases) and 289 JAN07 DNH (1 case) not been produced in the facility producer of powdered milk Picot.
An investigation into the group's factory Blédina where these lots were made showed that they had been conditioned in this factory, just after lots and 1229/BL7 1231/BL9, produced by the facility producer of powdered milk Picot brand on the same packaging line.
On 29 April, the company has Blédina implemented the withdrawal of the marketing of these lots:
- Blédilait 2: 900g - JAN07 - Lot: 289/DNH
- Blédilait 2: 900g - JAN07 - Lot: 290/DNH
InVS, in collaboration with the NRC for Salmonella, is continuing its investigations to ensure the effectiveness of these measures.
Reminders on Salmonella
Salmonella infections occur within three days after eating a contaminated product and cause an array of gastroenteritis with vomiting, sometimes bloody diarrhea, and fever in most cases. The appearance of these signs in an infant should lead families to seek medical attention.
Salmonella Agona is part of the 2,000 Salmonella serotypes pathogenic to man. From 2000 to 2004, CNR Salmonella has identified about a hundred strains of human Salmonella Agona year. Like most other serotypes of Salmonella serotype Agona is found in France in various reservoirs including poultry, cattle, pigs and cattle feed [1].
Four outbreaks of Salmonella Agona has been reported before in other countries, including one attributed to the consumption of milk powder [2]. The other 3 were due to consumption of herbal teas containing fennel and anise [3], snack peanut [4], and oat-based cereals [3].
References
- Brisabois A, Fremy S, Gauchard F, et al. Inventory of Salmonella 2002. French Agency for Food Safety, June 2004
- From the Centers for Disease Control and Prevention. Multistate outbreak of Salmonella serotype Agona infections linked to toasted oats cereal - United States, April-May, 1998. JAMA. 1998; 280 (5): 411
- Koch J, Schrauder A, Werber D, Alpers K, Rabsch W, Prager R, Broll S, Frank C, Roggentin P Tschäpe H, Ammon A and K. Stark A nation-wide outbreak of Salmonella Agona in infants due to Aniseed in herbal tea, Germany, October 2002-July 2003. 5th World Congress Foodborne Infections and intoxications, 7-11 June 2004, Berlin, Germany
- Killalea D, Ward LR, Roberts D, et al. International Epidemiological and Microbiological study of outbreak of Salmonella Agona infection from a ready to eat savory snack - I: England and Wales and the United States. BMJ 1996; 311-13